AlphaGrep UK Ltd increased its position in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 296.2% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,060 shares of the semiconductor company’s stock after purchasing an additional 1,540 shares during the period. AlphaGrep UK Ltd’s holdings in Synopsys were worth $896,000 as of its most recent SEC filing.
A number of other hedge funds have also recently added to or reduced their stakes in the company. Elevation Wealth Partners LLC raised its stake in shares of Synopsys by 96.4% during the 2nd quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock worth $25,000 after buying an additional 27 shares in the last quarter. Osbon Capital Management LLC acquired a new stake in shares of Synopsys in the 2nd quarter valued at approximately $25,000. IMG Wealth Management Inc. purchased a new stake in shares of Synopsys in the second quarter valued at approximately $28,000. GK Wealth Management LLC purchased a new stake in shares of Synopsys in the third quarter valued at approximately $28,000. Finally, EFG International AG acquired a new position in Synopsys during the second quarter worth $34,000. Institutional investors and hedge funds own 85.47% of the company’s stock.
Wall Street Analyst Weigh In
SNPS has been the subject of several research analyst reports. Roth Capital upgraded Synopsys to a “buy” rating in a research report on Friday, September 25th. UBS Group set a $570.00 price target on shares of Synopsys in a research note on Thursday, August 27th. Benchmark reiterated a “buy” rating and issued a $570.00 price target on shares of Synopsys in a report on Thursday, August 27th. Weiss Ratings downgraded shares of Synopsys from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday, September 11th. Finally, Rosenblatt Securities raised their price objective on shares of Synopsys from $575.00 to $620.00 and gave the company a “buy” rating in a research note on Thursday, October 1st. One research analyst has rated the stock with a Strong Buy rating, twenty-two have issued a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $577.71.
Synopsys Stock Performance
Shares of SNPS opened at $396.55 on Friday. The company has a current ratio of 1.34, a quick ratio of 1.24 and a debt-to-equity ratio of 0.29. The stock has a market cap of $76.00 billion, a P/E ratio of 70.06, a PEG ratio of 1.26 and a beta of 1.18. The company has a 50-day moving average of $448.46 and a two-hundred day moving average of $440.14. Synopsys, Inc. has a 12-month low of $362.55 and a 12-month high of $539.48.
Synopsys (NASDAQ:SNPS – Get Free Report) last issued its quarterly earnings data on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share for the quarter, topping analysts’ consensus estimates of $3.67 by $0.24. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. The business had revenue of $2.48 billion during the quarter, compared to analysts’ expectations of $2.44 billion. During the same period last year, the company posted $3.39 EPS. The company’s revenue was up 42.4% on a year-over-year basis. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. As a group, research analysts predict that Synopsys, Inc. will post 11.01 EPS for the current fiscal year.
Synopsys announced that its Board of Directors has approved a share buyback plan on Monday, October 5th that allows the company to repurchase $1 billion in outstanding shares. This repurchase authorization allows the semiconductor company to reacquire up to 1.1% of its shares through open market purchases. Share repurchase plans are typically a sign that the company’s board believes its stock is undervalued.
Insider Buying and Selling
In related news, CFO Sudhindra Kankanwadi sold 9,170 shares of Synopsys stock in a transaction dated Tuesday, October 6th. The stock was sold at an average price of $500.00, for a total transaction of $4,585,000.00. Following the completion of the sale, the chief financial officer owned 22,717 shares in the company, valued at approximately $11,358,500. This trade represents a 28.76% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Sassine Ghazi sold 14,604 shares of the company’s stock in a transaction dated Thursday, October 15th. The shares were sold at an average price of $462.84, for a total transaction of $6,759,315.36. Following the completion of the transaction, the chief executive officer owned 76,865 shares in the company, valued at approximately $35,576,196.60. This trade represents a 15.97% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 117,163 shares of company stock worth $51,366,457. 0.56% of the stock is owned by company insiders.
Recent Synopsys Headlines
Investors following SNPS have been watching these headlines:
- Positive Sentiment: Barclays initiated coverage with an Overweight rating and a $640 price target, citing Synopsys’ leadership in electronic design automation, AI-related R&D tailwinds and long-term free-cash-flow potential. The bullish call was accompanied by a gain in Thursday trading. Barclays starts Synopsys at Overweight
- Neutral Sentiment: Synopsys is described as having stronger forward growth and a lower forward valuation multiple than Cadence, but Cadence is credited with a stronger balance sheet and returns on capital. Synopsys vs. Cadence
- Negative Sentiment: A valuation analysis argues SNPS may be about 17% overvalued despite improving guidance and business performance, raising questions about whether future cash generation justifies the share price. Synopsys may be overvalued
About Synopsys
Synopsys, Inc. develops software, semiconductor intellectual property (IP) and services used to design and verify electronic systems. Its electronic design automation (EDA) tools help customers create, simulate, test and validate chips and other complex electronic products, while its IP portfolio provides reusable building blocks for semiconductor designs. The company also offers software security and quality tools that help developers identify vulnerabilities and assess applications throughout the software development process.
Featured Articles
- Five stocks we like better than Synopsys
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
- Owens Corning’s Stock Slump May Have a Silver Lining for Dividend Investors
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
